In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Tension has increased in the relations between India and Canada in the last few months. Canadian
Services sector activity in India rose to a three-month high in November on strong demand. The S&
Today's Weather Update. The severity of winter is going to increase in North India. At the same t
Akshaye Khanna played the role of the dacoit Rehman in the movie Dhurandhar. As soon as the film
South superstar Rajinikanth has been given a golden visa by the Culture and Tourism Department of
The ending (post-credits scene) of Venom's second film 'Venom: Let There Be Carnage' from Marvel
Rate Hike: US Fed Chairman consoles, hints at easing rate hike during next meeting
US Federal Reserve Chairman Jerome Powell comforted on Wednesday that interest rate hikes could b
The Sino-Russian-led Shanghai Cooperation Organization is holding a summit meeting in Samarkand c
Religious Freedom Report: India rejects US report on religious freedom, know what is in it?
The US State Department has released its annual report on International Religious Freedom. The re
Ranveer Allahabadia Case The Supreme Court will hear Ranveer Allahabadia's petition against the F
